Breaking News Instant updates and real-time market news.

RXDX

Ignyta

$26.85

11.3 (72.67%)

08:40
12/26/17
12/26
08:40
12/26/17
08:40

Ignyta downgraded to Hold from Buy at SunTrust

SunTrust downgraded Ignyta (RXDX) to Hold after the company agreed to be acquired by Roche (RHHBY) for $27 per share.

RXDX Ignyta
$26.85

11.3 (72.67%)

11/21/17
RHCO
11/21/17
INITIATION
Target $25
RHCO
Buy
Ignyta initiated with a Buy at SunTrust on lead drug prospects
As reported earlier, SunTrust analyst Peter Lawson initiated Ignyta with a Buy rating and a price target of $25. Lawson says Ignyta is "one of the most compelling stories in targeted medicine" as its lead drug addresses two genetically defined cancer subtypes with high efficacy and a cleaner side effect profile. The analyst anticipates a 2019 launch for the treatment, adding that the company also offers a series of potential positive data releases in 2018 that could drive the price upside.
12/22/17
JEFF
12/22/17
DOWNGRADE
Target $27
JEFF
Hold
Ignyta downgraded to Hold from Buy at Jefferies
Jefferies analyst Maury Raycroft downgraded Ignyta (RXDX) to Hold after the company reached an agreement to be acquired by Roche (RHHBY). The analyst maintains a $27 price target for shares.He expects the deal to close.
12/22/17
STFL
12/22/17
NO CHANGE
STFL
Buy
Roche deal has postive read-through for Loxo Oncology, says Stifel
Stifel analyst Stephen Willey anticipates bears will say Roche's (RHHBY) deal for Ignyta (RXDX) reflects the potential competitiveness of Ignyta's entrectinib relative to Loxo Oncology's (LOXO) larotrectinib in malignancies caused by NTRK fusions. However, he is "firmly" in the bull camp that Roche's acquisition was primarily focused around the opportunity for entrectinib in treating ROS-1 fusions in NSCLC and that this deal reflects big pharma's appetite for targeted agents and long-duration oncology assets. Willey has a Buy rating on Loxo shares.
12/26/17
LTCO
12/26/17
DOWNGRADE
LTCO
Neutral
Ignyta downgraded to Neutral from Buy at Ladenburg
Ladenburg Thalmann analyst Kevin Degeeter downgraded Ignyta (RXDX) to Neutral after the company agreed to be acquired by Roche (RHHBY) for $27 per share.

TODAY'S FREE FLY STORIES

GIS

General Mills

$42.00

0.23 (0.55%)

11:40
05/22/18
05/22
11:40
05/22/18
11:40
Conference/Events
General Mills management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

MYND

MYnd Analytics

$2.66

-0.5 (-15.82%)

11:33
05/22/18
05/22
11:33
05/22/18
11:33
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$620.18

-45.5 (-6.84%)

11:32
05/22/18
05/22
11:32
05/22/18
11:32
Technical Analysis
Technical Take: AutoZone back near lows of the day »

After a brief bounce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TJX

TJX

$87.50

2.84 (3.35%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Earnings
TJX sees Q2 revenue approx. $9B, consensus $8.47B »

Expects wage increases to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RCII

Rent-A-Center

$10.07

-0.14 (-1.37%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Options
Notable ratio spread in Rent A Center »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$86.77

2.11 (2.49%)

11:28
05/22/18
05/22
11:28
05/22/18
11:28
Earnings
TJX sees FY19 revenue $37.7B-$37.9B, consensus $37.87B »

Expects pretax profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TGT

Target

$76.39

-0.47 (-0.61%)

, AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

11:27
05/22/18
05/22
11:27
05/22/18
11:27
Earnings
On The Fly: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$76.39

-0.47 (-0.61%)

AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

WMT

Walmart

$84.33

-0.17 (-0.20%)

SHLD

Sears

$3.35

-0.29 (-7.97%)

JCP

J.C. Penney

$2.41

-0.1 (-3.99%)

KSS

Kohl's

$61.15

-4.32 (-6.60%)

W

Wayfair

$84.92

-0.6 (-0.70%)

TSLA

Tesla

$277.25

-7.24 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 01

    Jun

  • 04

    Jun

  • 19

    Jun

11:25
05/22/18
05/22
11:25
05/22/18
11:25
Conference/Events
RBC commodity strategist to hold a luncheon meeting »

Group Luncheon Meeting,…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary  »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ADSK

Autodesk

$138.56

1.05 (0.76%)

11:20
05/22/18
05/22
11:20
05/22/18
11:20
Options
Autodesk calls active ahead of earnings »

Autodesk calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

TJX

TJX

$86.18

1.52 (1.80%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Hot Stocks
TJX 'disproportionally' attracting millennial customers »

TJX "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/22/18
05/22
11:16
05/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/18
05/22
11:15
05/22/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

TJX

TJX

$86.14

1.48 (1.75%)

11:13
05/22/18
05/22
11:13
05/22/18
11:13
Recommendations
TJX analyst commentary  »

JPMorgan stays Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

CCJ

Cameco

$10.72

-0.66 (-5.80%)

11:10
05/22/18
05/22
11:10
05/22/18
11:10
Options
Call buyers in Cameco as shares see relative weakness »

Call buyers in Cameco as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$41.71

0.38 (0.92%)

11:08
05/22/18
05/22
11:08
05/22/18
11:08
Conference/Events
Suncor management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

SAGE

Sage Therapeutics

$161.81

-1.43 (-0.88%)

11:04
05/22/18
05/22
11:04
05/22/18
11:04
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

BMRN

BioMarin

$85.86

-3.49 (-3.91%)

11:01
05/22/18
05/22
11:01
05/22/18
11:01
Recommendations
BioMarin analyst commentary  »

BioMarin weakness on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

IGT

International Game

$27.74

-2.01 (-6.76%)

11:00
05/22/18
05/22
11:00
05/22/18
11:00
Options
International Game Tech calls active as shares slide »

International Game Tech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 02

    Aug

  • 24

    May

CCK

Crown Holdings

$45.34

0.68 (1.52%)

10:57
05/22/18
05/22
10:57
05/22/18
10:57
Conference/Events
Crown Holdings management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

10:55
05/22/18
05/22
10:55
05/22/18
10:55
Conference/Events
Stephens E&P analysts to hold a group luncheon »

Exploration &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.